Algeria vs Djibouti: Previously treated cases tested for RR-/MDR-TB
Algeria
8.2%
in 2023
Djibouti
17.0%
in 2022
Algeria rank
168th
Djibouti rank
166th
Previously treated cases tested for RR-/MDR-TB over time
- Algeria
- Djibouti
How they compare
Djibouti currently reports 17.0% against 8.2% in Algeria, a difference of 8.8%.
That makes Djibouti's figure about 2.1 times Algeria's.
The two have swapped places 2 times across 8 shared years of data; in 2005 it was Algeria ahead.
Algeria ranks 168th and Djibouti ranks 166th of 180 countries.
Across the 3 decades both report, Algeria averaged higher in 2 and Djibouti in 1.
Head to head by decade
| Decade | Algeria | Djibouti | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 23.0% | 0.0% | 23.0% | Algeria |
| 2010s | 38.4% | 73.8% | 35.4% | Djibouti |
| 2020s | 24.0% | 17.0% | 7.0% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Algeria or Djibouti?
- Djibouti, at 17.0% against 8.2% in Algeria as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Algeria and Djibouti?
- 8.8%, with Djibouti ahead.
- How many years of comparable data are there for Algeria and Djibouti?
- 8 years are reported by both, from 2005 to 2022.
- How do Algeria and Djibouti rank globally for previously treated cases tested for rr-/mdr-tb?
- Algeria ranks 168th and Djibouti ranks 166th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.